The efficiency of tumor development can be increased by inducing conditional homozygous Ptch1 deletion in relevant stem/progenitor cell populations16, 17 or by breeding Ptch1+/− mice to a Trp53-null background18, which is also seen in a proportion of patients with highly aggressive human SHH MB19. This evidence concerns the gene TP53 and neoplasm.